FT709
FT709 is a potent and selective USP9X inhibitor, an IC50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemo-sensitization, and circadian rhythms[1].
Product Specifications
CAS Number
2413991-74-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Deubiquitinase; Mitosis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ft709.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C1=CN=C2C(OCCO2)=C1)(N3CC(CN(C([C@@H](O)C4=CC=CC5=C4N=C(C)O5)=O)C6)=C6C3)=O
Molecular Formula
C23H22N4O7S
Molecular Weight
498.51
Precautions
H302, H315, H319
References & Citations
[1]Clancy A, et, al. The deubiquitylase USP9X controls ribosomal stalling. J Cell Biol. 2021 Mar 1;220 (3) :e202004211.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alpha neoendorphin Rabbit Polyclonal Antibody (Cy7)